-
Zlotoff Generations Fund
The Zlotoff Generations Fund gifted $250,000 toward a partnership between Dana-Farber Cancer Institute and Ichilov, the Tel Aviv Sourasky Medical Center, Israel’s leading academic medical center and largest public acute care facility. This generosity will support research in AI and advanced breast cancer, as well as work in early detection and clinical education.
-
Funding the future: Focusing on excellence through endowments
Earlier detection. Better treatments. More time with loved ones. Breakthroughs in cancer care don’t happen by chance—they’re driven by exceptional faculty pursuing bold ideas.
-
From early career to endowed leadership: Larry and Susan Marx fuel early detection
Larry and Susan Marx have always been guided by the conviction that investing in bright minds can shape careers and accelerate breakthroughs.
-
Damon Runyon Cancer Research Foundation celebrates the next generation of scientists
The Damon Runyon Cancer Research Foundation awarded grants, totaling more than $3 million, to Dana-Farber investigators working across cancer types.
-
Breast Cancer Research Foundation fuels world-class research
In support of their mission to prevent and cure breast cancer, the Breast Cancer Research Foundation (BCRF) recently made grants totaling approximately $3.3 million to 17 of Dana-Farber Cancer Institute’s investigators.
-
V Foundation accelerates progress against cancer
To date, the V Foundation has given more than $458 million in grants to support the world’s best cancer scientists, including $2.8 million in recent grants to four brilliant Dana-Farber Cancer Institute investigators.
-
Massachusetts Life Sciences Center powers breakthroughs
As part of its Commonwealth-wide funding efforts, the MLSC awarded five grants, totaling more than $2.2 million, to Dana-Farber’s Jose Cancelas, MD, PhD, Laurie H. Glimcher, MD, Henry Long, PhD, Filipa Lynce, MD, and the Continuing Umbrella of Research Experiences (CURE) program.
-
Cinelli Family Foundation invests in stopping cancer before it starts
Chances of survival increase when cancer is detected early––yet most cancers don’t have screening tests. Elizabeth O’Donnell, MD, and her team at Dana-Farber Cancer Institute’s Centers for Early Detection and Interception are taking steps to fill these critical gaps through clinical trials that evaluate newly developed multi-cancer early detection (MCED) tests.
-
Advancing blood cancer research with the Edward P. Evans Foundation
A steadfast supporter since 2013, the Edward P. Evans Foundation continued their generous contributions by investing $1.315 million in three Dana-Farber researchers over the past year.
-
Mathers Foundation funds bold steps in immunotherapy research
The G. Harold and Leila Y. Mathers Charitable Foundation awarded $1.4 million to Dana-Farber Cancer Institute.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.